Use of Potent Topical Corticosteroids (TCS) for Hypergranulation Tissue (HGT) in Pediatric Patients

Shae Margulies1, Tyler Marion1, Sami K Saikaly1

  • 1Department of Dermatology, University of Florida College of Medicine, Gainesville, USA.

Cureus
|September 26, 2022
PubMed

Insights

Topical corticosteroids (TCS) offer a non-invasive treatment for hypergranulation tissue (HGT) in pediatric wound healing. This approach is effective and should be considered for managing HGT in children.

Area of Science:

  • Dermatology
  • Wound Healing
  • Pediatric Care

Background:

  • Hypergranulation tissue (HGT) is a frequent complication in wound healing, characterized by excess granulation tissue.
  • This condition impedes healing and reepithelialization, posing challenges for clinicians.
  • Pediatric patients often benefit from less invasive and irritating treatment options.

Observation:

  • A case study involved a 14-year-old female with scalp HGT.
  • The HGT was successfully managed using topical corticosteroids (TCS).

Findings:

  • Topical corticosteroids (TCS) demonstrated efficacy in treating hypergranulation tissue (HGT) in a pediatric case.
  • A literature review indicated that TCS, while not a primary treatment, is a viable option for pediatric HGT.

Implications:

  • Topical corticosteroids (TCS) represent a non-invasive and painless therapeutic option for pediatric hypergranulation tissue (HGT).
  • Consideration of TCS is warranted for managing HGT in the pediatric population, especially when less invasive methods are preferred.

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
190
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
364
Burn Injuries01:22

Burn Injuries

Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
2.7K